Reversibility of lysosomal and glucose 6-phosphatase changes produced in the rat liver by dimethylnitrosamine.
The present investigation was undertaken to discover whether repeated doses of dimethylnitrosamine (DMNA) could produce a cumulative toxic effect on the rat liver. For this purpose doses were selected at a level just too low to produce cytopathological changes, as indicated by depression of glucose-6-phosphatase and induction of autophagic vacuoles (AV) in hepatocytes, when given once only. Single subcutaneous injections of 10 or 3 mg/kg induced these cytopathological changes in the centrilobular (CLB) hepatic cells but when the dose was reduced to 1 mg/kg no such changes were seen. After daily administration of 1 mg/kg for 4 or 8 weeks we observed both glucose-6-phosphatase depression and autophagy, and in addition there was marked hypertrophy of the rough endoplasmic reticulum, nucleolar microsegregation and the appearance of distorted, often ring-shaped mitochondria with shortened cristae. Kupffer cells exhibited a marked increase in lysosomal activity. With the exception of mitochondrial changes and Kupffer cell activity this same picture was observed, although in milder form, when the dose administered was 0.3 or 0.1 mg/kg daily for the same period. When treatment was continued for 12 weeks, however, the only differences from control rats were the presence of hypertrophied rough endoplasmic reticulum (RER) at all three dose levels, nucleolar microsegregation at the upper two dose levels, and pronounced Kupffer cell activity at the top dose. These findings indicate that cumulative cytopathologic effects occur only up to 8 weeks at the dose levels studied but hypertrophy of RER and increased Kupffer cell activity persist up to 12 weeks.
D000135:Acid Phosphatase / Q000378:metabolism; D000818:Animals; D002466:Cell Nucleolus / Q000648:ultrastructure; D004128:Dimethylnitrosamine / Q000008:administration & dosage / Q000494:pharmacology*; D004721:Endoplasmic Reticulum / Q000648:ultrastructure; D005260:Female; D005952:Glucose-6-Phosphatase / Q000378:metabolism*; D007279:Injections, Subcutaneous; D007728:Kupffer Cells / Q000648:ultrastructure; D008099:Liver / Q000187:drug effects* / Q000648:ultrastructure; D008247:Lysosomes / Q000187:drug effects* / Q000201:enzymology / Q000648:ultrastructure; D008854:Microscopy, Electron; D008930:Mitochondria, Liver / Q000648:ultrastructure; D009602:Nitrosamines / Q000494:pharmacology*; D051381:Rats; D013997:Time Factors; D014617:Vacuoles
D009602:Nitrosamines; D000135:Acid Phosphatase; D005952:Glucose-6-Phosphatase; D004128:Dimethylnitrosamine